Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Steer Clear of Biogen's $12 Billion Checkup

Wall Street Journal - 4 Dec 2019 14:03
With new Alzheimer's disease drug data coming from Biogen, neither bulls nor bears can rest easy.
Full Article at Wall Street Journal

More Market News
3
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard